Brief: Core Laboratories NV - Q2 GAAP EPS $0.15
July 27 (Reuters) - Core Laboratories NV CLB.N :
* CORE LABORATORIES NV - Q2 REVENUE OF $120.9 MILLION; UP 5%
SEQUENTIALLY; UP 2% YEAR-OVER-YEAR
* CORE LABORATORIES NV - Q2 GAAP EPS OF $0.15; EPS,
EX-ITEMS,
$0.12
* CORE LABORATORIES NV - RENEWS AND EXTENDS REVOLVING CREDIT
FACILITY THROUGH 2026
Source text: [ID: https://bit.ly/3OAe27H]
Further company coverage: CLB.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Core Laboratories
See all newsCore Laboratories Inc reports results for the quarter ended June 30 - Earnings Summary
Core Laboratories Q2 revenue falls as geopolitical disruptions weigh
Brief: Core Laboratories Q2 EPS USD 0.13
Core Laboratories Inc expected to post earnings of 9 cents a share - Earnings Preview
Core Laboratories Q1 profit halves as Middle East disruptions, weather weigh